Table of contents
August 2008, Volume 26 No 8 pp855-952
- In This Issue
- Bioentrepreneur
- Editorial
- News
- Opinion and Comment
- Features
- News and Views
- Computational Biology
- Research
- Errata
- Naturejobs
Editorial
Join the dots - p837
doi:10.1038/nbt0808-837
Pushing biotech as the 'solution' to the world's problems is doing more harm than good.
Abstract - | Full Text - Join the dots | PDF (105 KB) - Join the dots
News
EGFR inhibitors embrace KRAS - pp839 - 840
Cormac Sheridan
doi:10.1038/nbt0808-839
Full Text - EGFR inhibitors embrace KRAS | PDF (201 KB) - EGFR inhibitors embrace KRAS
GSK slashes internal R&D - p840
Nuala Moran
doi:10.1038/nbt0808-840
Full Text - GSK slashes internal R&D | PDF (92 KB) - GSK slashes internal R&D
Myriad stumbles, Wyeth closes on Alzheimer's - pp841 - 843
Randy Osborne
doi:10.1038/nbt0808-841
Full Text - Myriad stumbles, Wyeth closes on Alzheimer's | PDF (212 KB) - Myriad stumbles, Wyeth closes on Alzheimer's
FDA and surrogate endpoints in Alzheimer's disease - p843
Randy Osborne
doi:10.1038/nbt0808-843
Full Text - FDA and surrogate endpoints in Alzheimer's disease | PDF (56 KB) - FDA and surrogate endpoints in Alzheimer's disease
Infections cast cloud over Novartis' MS therapy - pp844 - 845
Ken Garber
doi:10.1038/nbt0808-844
Full Text - Infections cast cloud over Novartis' MS therapy | PDF (227 KB) - Infections cast cloud over Novartis' MS therapy
India harmonizes regulations - p845
K S Jayaraman
doi:10.1038/nbt0808-845a
Full Text - India harmonizes regulations | PDF (66 KB) - India harmonizes regulations
FDA probes TNF blockers - p845
Brady Huggett
doi:10.1038/nbt0808-845b
Full Text - FDA probes TNF blockers | PDF (66 KB) - FDA probes TNF blockers
GSK bird flu vaccine - p846
Susan Aldridge
doi:10.1038/nbt0808-846a
Full Text - GSK bird flu vaccine | PDF (109 KB) - GSK bird flu vaccine
Cabilly patent finale - p846
Emily Waltz
doi:10.1038/nbt0808-846b
Full Text - Cabilly patent finale | PDF (109 KB) - Cabilly patent finale
UK strong arms industry over drug pricing - pp846 - 847
Peter Mitchell
doi:10.1038/nbt0808-846c
Full Text - UK strong arms industry over drug pricing | PDF (123 KB) - UK strong arms industry over drug pricing
Pharma to boycott UK? - p847
Peter Mitchell
doi:10.1038/nbt0808-847a
Full Text - Pharma to boycott UK? | PDF (63 KB) - Pharma to boycott UK?
EC/FDA joint inspections - p847
Barbara Nasto
doi:10.1038/nbt0808-847b
Full Text - EC/FDA joint inspections | PDF (63 KB) - EC/FDA joint inspections
Supply size matters - p847
Susan Aldridge
doi:10.1038/nbt0808-847c
Full Text - Supply size matters | PDF (63 KB) - Supply size matters
Profile: Olivier Rabin - p849
Henry Nicholls
doi:10.1038/nbt0808-849
With Beijing 2008 in full swing, the World Anti-Doping Agency's Olivier Rabin is looking for help from the biotech and pharma industry in the battle against cheaters.
Abstract - | Full Text - Profile: Olivier Rabin | PDF (104 KB) - Profile: Olivier Rabin
Data Page
Q2 finance fall-off - p850
Stacy Lawrence
doi:10.1038/nbt0808-850
Full Text - Q2 finance fall-off | PDF (291 KB) - Q2 finance fall-off
News Feature
Do biomaterials really mean business? - pp851 - 853
Emily Waltz
doi:10.1038/nbt0808-851
Receiving only a fraction of the investment set aside for biofuels, biomaterials will likely have to piggyback on technological advances in energy production to compete with petroleum-based products in the marketplace. Emily Waltz reports.
Abstract - | Full Text - Do biomaterials really mean business? | PDF (153 KB) - Do biomaterials really mean business?
Bioentrepreneur
Building a business
The economics of licensing contracts - pp855 - 857
Richard Mason, Nicos Savva & Stefan Scholtes
doi:10.1038/bioe.2008.7
Opinion and Comment
Correspondence
GMO testing—trade, labeling or safety first? - pp858 - 859
Arne Holst-Jensen
doi:10.1038/nbt0808-858
Full Text - GMO testing—trade, labeling or safety first? | PDF (191 KB) - GMO testing—trade, labeling or safety first?
First evaluation of the European hESCreg - pp859 - 860
Joeri Borstlap, Glyn Stacey, Andreas Kurtz, Anja Elstner, Alexander Damaschun, Begoña Arán & Anna Veiga
doi:10.1038/nbt0808-859
Full Text - First evaluation of the European hESCreg | PDF (197 KB) - First evaluation of the European hESCreg
Guidelines for reporting the use of mass spectrometry in proteomics - pp860 - 861
Chris F Taylor, Pierre-Alain Binz, Ruedi Aebersold, Michel Affolter, Robert Barkovich, Eric W Deutsch, David M Horn, Andreas Hühmer, Martin Kussmann, Kathryn Lilley, Marcus Macht, Matthias Mann, Dieter Müller, Thomas A Neubert, Janice Nickson, Scott D Patterson, Roberto Raso, Kathryn Resing, Sean L Seymour, Akira Tsugita, Ioannis Xenarios, Rong Zeng & Randall K Julian, Jr
doi:10.1038/nbt0808-860
Full Text - Guidelines for reporting the use of mass spectrometry in proteomics | PDF (154 KB) - Guidelines for reporting the use of mass spectrometry in proteomics | Supplementary information
Guidelines for reporting the use of mass spectrometry informatics in proteomics - p862
Pierre-Alain Binz, Robert Barkovich, Ronald C Beavis, David Creasy, David M Horn, Randall K Julian, Jr, Sean L Seymour, Chris F Taylor & Yves Vandenbrouck
doi:10.1038/nbt0808-862
Full Text - Guidelines for reporting the use of mass spectrometry informatics in proteomics | PDF (77 KB) - Guidelines for reporting the use of mass spectrometry informatics in proteomics | Supplementary information
Guidelines for reporting the use of gel electrophoresis in proteomics - pp863 - 864
Frank Gibson, Leigh Anderson, Gyorgy Babnigg, Mark Baker, Matthias Berth, Pierre-Alain Binz, Andy Borthwick, Phil Cash, Billy W Day, David B Friedman, Donita Garland, Howard B Gutstein, Christine Hoogland, Neil A Jones, Alamgir Khan, Joachim Klose, Angus I Lamond, Peter F Lemkin, Kathryn S Lilley, Jonathan Minden, Nicholas J Morris, Norman W Paton, Michael R Pisano, John E Prime, Thierry Rabilloud, David A Stead, Chris F Taylor, Hans Voshol, Anil Wipat & Andrew R Jones
doi:10.1038/nbt0808-863
Full Text - Guidelines for reporting the use of gel electrophoresis in proteomics | PDF (157 KB) - Guidelines for reporting the use of gel electrophoresis in proteomics | Supplementary information
The PSI-MOD community standard for representation of protein modification data - pp864 - 866
Luisa Montecchi-Palazzi, Ron Beavis, Pierre-Alain Binz, Robert J Chalkley, John Cottrell, David Creasy, Jim Shofstahl, Sean L Seymour & John S Garavelli
doi:10.1038/nbt0808-864
Full Text - The PSI-MOD community standard for representation of protein modification data | PDF (101 KB) - The PSI-MOD community standard for representation of protein modification data
Features
Off-label or off-limits? - pp867 - 875
Mark Ratner & Trisha Gura
doi:10.1038/nbt0808-867
Off-label prescribing is a fundamental fact of life of healthcare systems, but the promotion of off-label uses by drug sponsors is a fundamental sin. Regulators, legislators and drug makers are wrestling to find the right balance.
Abstract - | Full Text - Off-label or off-limits? | PDF (264 KB) - Off-label or off-limits?
Patents
The London Agreement and the future of parallel imports - pp877 - 879
Justine Muir
doi:10.1038/nbt0808-877
Are European patents really getting cheaper, and if so, what effect will this have on parallel or so-called gray imports?
Abstract - | Full Text - The London Agreement and the future of parallel imports | PDF (250 KB) - The London Agreement and the future of parallel imports
Recent patent applications in DNA synthesis - p880
doi:10.1038/nbt0808-880
Full Text - Recent patent applications in DNA synthesis | PDF (59 KB) - Recent patent applications in DNA synthesis
News and Views
Sequencing sliced ends reveals microRNA targets - pp881 - 882
Ian R Henderson & Steven E Jacobsen
doi:10.1038/nbt0808-881
Global sequencing of cleaved mRNAs enables identification of the targets of microRNA silencing.
Abstract - | Full Text - Sequencing sliced ends reveals microRNA targets | PDF (146 KB) - Sequencing sliced ends reveals microRNA targets
See also: Research by German et al.
Nematology: terra incognita no more - pp882 - 884
James P McCarter
doi:10.1038/nbt0808-882
The genome sequence of the plant-parasitic roundworm Meloidogyne incognita opens new avenues to boosting food production.
Abstract - | Full Text - Nematology: terra incognita no more | PDF (503 KB) - Nematology: terra incognita no more
See also: Research by Abad et al.
Antibody-drug conjugates ace the tolerability test - pp884 - 885
Nitin K Damle
doi:10.1038/nbt0808-884
Near-uniform, low-level conjugation of cytotoxins to antitumor antibodies increases their tolerability without compromising efficacy.
Abstract - | Full Text - Antibody-drug conjugates ace the tolerability test | PDF (847 KB) - Antibody-drug conjugates ace the tolerability test
See also: Research by Junutula et al.
A welcome burst of human antibodies - pp886 - 887
Michael B Zwick, Johannes S Gach & Dennis R Burton
doi:10.1038/nbt0808-886
A new method allows rapid identification of human monoclonal antibodies from immune or vaccinated individuals.
Abstract - | Full Text - A welcome burst of human antibodies | PDF (698 KB) - A welcome burst of human antibodies
Research Highlights - p888
doi:10.1038/nbt0808-888
Full Text - Research Highlights | PDF (104 KB) - Research Highlights
Computational Biology
Commentary
Promoting coherent minimum reporting guidelines for biological and biomedical investigations: the MIBBI project - pp889 - 896
Chris F Taylor, Dawn Field, Susanna-Assunta Sansone, Jan Aerts, Rolf Apweiler, Michael Ashburner, Catherine A Ball, Pierre-Alain Binz, Molly Bogue, Tim Booth, Alvis Brazma, Ryan R Brinkman, Adam Michael Clark, Eric W Deutsch, Oliver Fiehn, Jennifer Fostel, Peter Ghazal, Frank Gibson, Tanya Gray, Graeme Grimes, John M Hancock, Nigel W Hardy, Henning Hermjakob, Randall K Julian, Jr, Matthew Kane, Carsten Kettner, Christopher Kinsinger, Eugene Kolker, Martin Kuiper, Nicolas Le Novère, Jim Leebens-Mack, Suzanna E Lewis, Phillip Lord, Ann-Marie Mallon, Nishanth Marthandan, Hiroshi Masuya, Ruth McNally, Alexander Mehrle, Norman Morrison, Sandra Orchard, John Quackenbush, James M Reecy, Donald G Robertson, Philippe Rocca-Serra, Henry Rodriguez, Heiko Rosenfelder, Javier Santoyo-Lopez, Richard H Scheuermann, Daniel Schober, Barry Smith, Jason Snape, Christian J Stoeckert, Jr, Keith Tipton, Peter Sterk, Andreas Untergasser, Jo Vandesompele & Stefan Wiemann
doi:10.1038/nbt.1411
The Minimum Information for Biological and Biomedical Investigations (MIBBI) project aims to foster the coordinated development of minimum-information checklists and provide a resource for those exploring the range of extant checklists.
Full Text - Promoting coherent minimum reporting guidelines for biological and biomedical investigations: the MIBBI project | PDF (233 KB) - Promoting coherent minimum reporting guidelines for biological and biomedical investigations: the MIBBI project | Supplementary information
Primer
What is the expectation maximization algorithm? - pp897 - 899
Chuong B Do & Serafim Batzoglou
doi:10.1038/nbt1406
The expectation maximization algorithm arises in many computational biology applications that involve probabilistic models. What is it good for, and how does it work?
Abstract - | Full Text - What is the expectation maximization algorithm? | PDF (856 KB) - What is the expectation maximization algorithm? | Supplementary information
Research
Perspective
Neutralizing antibodies to therapeutic enzymes: considerations for testing, prevention and treatment - pp901 - 908
Jinhai Wang, Jay Lozier, Gibbes Johnson, Susan Kirshner, Daniela Verthelyi, Anne Pariser, Elizabeth Shores & Amy Rosenberg
doi:10.1038/nbt.1484
Abstract - | Full Text - Neutralizing antibodies to therapeutic enzymes: considerations for testing, prevention and treatment | PDF (1,124 KB) - Neutralizing antibodies to therapeutic enzymes: considerations for testing, prevention and treatment
Articles
Genome sequence of the metazoan plant-parasitic nematode Meloidogyne incognita - pp909 - 915
Pierre Abad, Jérôme Gouzy, Jean-Marc Aury, Philippe Castagnone-Sereno, Etienne G J Danchin, Emeline Deleury, Laetitia Perfus-Barbeoch, Véronique Anthouard, François Artiguenave, Vivian C Blok, Marie-Cécile Caillaud, Pedro M Coutinho, Corinne Dasilva, Francesca De Luca, Florence Deau, Magali Esquibet, Timothé Flutre, Jared V Goldstone, Noureddine Hamamouch, Tarek Hewezi, Olivier Jaillon, Claire Jubin, Paola Leonetti, Marc Magliano, Tom R Maier, Gabriel V Markov, Paul McVeigh, Graziano Pesole, Julie Poulain, Marc Robinson-Rechavi, Erika Sallet, Béatrice Ségurens, Delphine Steinbach, Tom Tytgat, Edgardo Ugarte, Cyril van Ghelder, Pasqua Veronico, Thomas J Baum, Mark Blaxter, Teresa Bleve-Zacheo, Eric L Davis, Jonathan J Ewbank, Bruno Favery, Eric Grenier, Bernard Henrissat, John T Jones, Vincent Laudet, Aaron G Maule, Hadi Quesneville, Marie-Noëlle Rosso, Thomas Schiex, Geert Smant, Jean Weissenbach & Patrick Wincker
doi:10.1038/nbt.1482
Biological control of the root-knot nematode Meloidogyne incognita, one of the world's most destructive crop pathogens, presents a major opportunity for safely improving global agricultural yields. Its 86-Mb genome—the first to be sequenced for a strictly parthenogenetic species—provides a blueprint to design new strategies for plant protection.
Abstract - | Full Text - Genome sequence of the metazoan plant-parasitic nematode Meloidogyne incognita | PDF (580 KB) - Genome sequence of the metazoan plant-parasitic nematode Meloidogyne incognita | Supplementary information
See also: News and Views by McCarter
A drug-inducible transgenic system for direct reprogramming of multiple somatic cell types - pp916 - 924
Marius Wernig, Christopher J Lengner, Jacob Hanna, Michael A Lodato, Eveline Steine, Ruth Foreman, Judith Staerk, Styliani Markoulaki & Rudolf Jaenisch
doi:10.1038/nbt1483
Generating induced pluripotent stem (iPS) cells is still an inefficient process, in part because the delivery of reprogramming factors by retroviral vectors yields cell populations that are genetically heterogeneous. Wernig et al. increase efficiency by producing iPS-cell chimeric mice from which they isolate cells bearing identical proviral insertions that support drug-inducible reprogramming.
Abstract - | Full Text - A drug-inducible transgenic system for direct reprogramming of multiple somatic cell types | PDF (1,515 KB) - A drug-inducible transgenic system for direct reprogramming of multiple somatic cell types | Supplementary information
Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index - pp925 - 932
Jagath R Junutula, Helga Raab, Suzanna Clark, Sunil Bhakta, Douglas D Leipold, Sylvia Weir, Yvonne Chen, Michelle Simpson, Siao Ping Tsai, Mark S Dennis, Yanmei Lu, Y Gloria Meng, Carl Ng, Jihong Yang, Chien C Lee, Eileen Duenas, Jeffrey Gorrell, Viswanatham Katta, Amy Kim, Kevin McDorman, Kelly Flagella, Rayna Venook, Sarajane Ross, Susan D Spencer, Wai Lee Wong, Henry B Lowman, Richard Vandlen, Mark X Sliwkowski, Richard H Scheller, Paul Polakis & William Mallet
doi:10.1038/nbt.1480
Systemic toxicity associated with heterogeneity in the stoichiometries and sites of drug attachment is a major hurdle to developing antibody-drug conjugates (ADCs) for cancer therapy. Junutula et al. engineer cysteine residues in constant domains to produce near-homogenous ADCs that are better tolerated than conventional ADCs, without any loss of antitumor activity.
Abstract - | Full Text - Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index | PDF (357 KB) - Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index | Supplementary information
See also: News and Views by Damle
A small molecule enhances RNA interference and promotes microRNA processing - pp933 - 940
Ge Shan, Yujing Li, Junliang Zhang, Wendi Li, Keith E Szulwach, Ranhui Duan, Mohammad A Faghihi, Ahmad M Khalil, Lianghua Lu, Zain Paroo, Anthony W S Chan, Zhangjie Shi, Qinghua Liu, Claes Wahlestedt, Chuan He & Peng Jin
doi:10.1038/nbt.1481
Little is known about the regulation of RNA interference (RNAi). Shan et al. constructed a reporter system to monitor RNAi activity and identified a small molecule that increases RNAi by facilitating the interaction between small RNAs and a protein involved in small RNA loading and processing.
Abstract - | Full Text - A small molecule enhances RNA interference and promotes microRNA processing | PDF (345 KB) - A small molecule enhances RNA interference and promotes microRNA processing | Supplementary information
Letter
Global identification of microRNA–target RNA pairs by parallel analysis of RNA ends - pp941 - 946
Marcelo A German, Manoj Pillay, Dong-Hoon Jeong, Amit Hetawal, Shujun Luo, Prakash Janardhanan, Vimal Kannan, Linda A Rymarquis, Kan Nobuta, Rana German, Emanuele De Paoli, Cheng Lu, Gary Schroth, Blake C Meyers & Pamela J Green
doi:10.1038/nbt1417
The targets of a microRNA (miRNA) are usually identified by computational analysis of sequences complementary to the miRNA. Working with inflorescence tissue of Arabidopsis, German et al. devise an experimental approach in which the products of miRNA-mediated cleavage are sequenced and used to identify miRNA–target RNA pairs.
First Paragraph - | Full Text - Global identification of microRNA–target RNA pairs by parallel analysis of RNA ends | PDF (643 KB) - Global identification of microRNA–target RNA pairs by parallel analysis of RNA ends | Supplementary information
See also: News and Views by Henderson & Jacobsen
Errata
Erratum: HIV vaccine controversy - p947
K S Jayaraman
doi:10.1038/nbt0808-947a
Full Text - Erratum: HIV vaccine controversy | PDF (59 KB) - Erratum: HIV vaccine controversy
Erratum: Response to HIV vaccine trials in India - p947
K S Jayaraman
doi:10.1038/nbt0808-947b
Full Text - Erratum: Response to HIV vaccine trials in India | PDF (59 KB) - Erratum: Response to HIV vaccine trials in India
Erratum: Can 'double blockbuster' strengthen Amgen's backbone? - p947
Cormac Sheridan
doi:10.1038/nbt0808-947c
Full Text - Erratum: Can 'double blockbuster' strengthen Amgen's backbone? | PDF (59 KB) - Erratum: Can 'double blockbuster' strengthen Amgen's backbone?
Erratum: Biotech slumps in Q1 - p947
Stacy Lawrence
doi:10.1038/nbt0808-947d
Full Text - Erratum: Biotech slumps in Q1 | PDF (59 KB) - Erratum: Biotech slumps in Q1
Naturejobs
Careers and Recruitment
Westernizing Eastern-bloc science - pp949 - 950
Quirin Schiermeier
doi:10.1038/nbt0808-949
Scientists in newer member countries are learning how to use what the European Union offers.
Abstract - | Full Text - Westernizing Eastern-bloc science | PDF (182 KB) - Westernizing Eastern-bloc science



